Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Psychiatric Medicine Associates
mi
from
Skokie, IL
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Psychiatric Medicine Associates
mi
from
Skokie, IL
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Integrative Clinical Trials, LLC
mi
from
Brooklyn, NY
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Integrative Clinical Trials, LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Finger Lakes Clinical Research
mi
from
Rochester, NY
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
IPS Research Company
mi
from
Oklahoma City, OK
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
KRK Medical Research
mi
from
Dallas, TX
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
KRK Medical Research
mi
from
Dallas, TX
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
InSite Clinical Research LLC
mi
from
DeSoto, TX
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Virginia Commonwealth University Clinical Research Services Unit
mi
from
Richmond, VA
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Virginia Commonwealth University Clinical Research Services Unit
mi
from
Richmond, VA
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Zain Research LLC
mi
from
Richland, WA
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Zain Research LLC
mi
from
Richland, WA
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Uptown Research Institute, Llc
mi
from
Chicago, IL
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Uptown Research Institute, Llc
mi
from
Chicago, IL
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Radiant Research/Comprehensive Clinical Development, Inc.
mi
from
Cerritos, CA
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Radiant Research/Comprehensive Clinical Development, Inc.
mi
from
Cerritos, CA
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated:  11/21/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression
Randomized Trial of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Major Depression
Status: Enrolling
Updated:  11/22/2017
Emory Executive Park
mi
from
Atlanta, GA
Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression
Randomized Trial of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Major Depression
Status: Enrolling
Updated: 11/22/2017
Emory Executive Park
mi
from
Atlanta, GA
Click here to add this to my saved trials
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
A Randomized, Double-Blind Placebo-controlled Study Evaluating the Efficacy of Omega 3 Fatty Acid Augmentation of Desvenlafaxine for the Treatment of Major Depressive Disorder in Patients With Medical Illness.
Status: Enrolling
Updated:  11/30/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
A Randomized, Double-Blind Placebo-controlled Study Evaluating the Efficacy of Omega 3 Fatty Acid Augmentation of Desvenlafaxine for the Treatment of Major Depressive Disorder in Patients With Medical Illness.
Status: Enrolling
Updated: 11/30/2017
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
Placebo-Controlled Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated:  12/5/2017
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
Placebo-Controlled Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated: 12/5/2017
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
Status: Enrolling
Updated:  12/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
Status: Enrolling
Updated: 12/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults
Status: Enrolling
Updated:  12/18/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults
Status: Enrolling
Updated: 12/18/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
ProScience Research Group
mi
from
Culver City, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
ProScience Research Group
mi
from
Culver City, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Synergy Clinical Research Center
mi
from
National City, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Synergy Clinical Research Center
mi
from
National City, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Scientific Clinical Research
mi
from
North Miami, FL
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Scientific Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Atlanta Center for Medical Research
mi
from
Atlanta, GA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Northwest Behavioral Research Center
mi
from
Marietta, GA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Northwest Behavioral Research Center
mi
from
Marietta, GA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Sheppard Pratt Health System
mi
from
Baltimore, MD
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
The Medical Research Network, LLC
mi
from
New York, NY
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Finger Lakes Clinical Research
mi
from
Rochester, NY
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Suburban Research Associates
mi
from
Media, PA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
FutureSearch Trials of Dallas
mi
from
Dallas, TX
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Arizona TMS Therapy Center
mi
from
Phoenix, AZ
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Arizona TMS Therapy Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Pacific Clinical Trials, LLC
mi
from
Oakland, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Pacific Clinical Trials, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Southern CA Psychiatrists
mi
from
Oceanside, CA
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Southern CA Psychiatrists
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Chicago Psychiatry Associates
mi
from
Chicago, IL
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Chicago Psychiatry Associates
mi
from
Chicago, IL
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
PCRC
mi
from
O'Fallon, MO
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
PCRC
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated:  12/19/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Status: Enrolling
Updated: 12/19/2017
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Clinical Study of Generic and Brand Bupropion in Depression
Bioequivalence and Clinical Effects of Generic and Brand Bupropion
Status: Enrolling
Updated:  12/20/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Clinical Study of Generic and Brand Bupropion in Depression
Bioequivalence and Clinical Effects of Generic and Brand Bupropion
Status: Enrolling
Updated: 12/20/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Influenza Challenge in Mood Disorders
Influenza Challenge in Mood Disorders
Status: Enrolling
Updated:  12/27/2017
Laureate Institute for Brian Research
mi
from
Tulsa, OK
Influenza Challenge in Mood Disorders
Influenza Challenge in Mood Disorders
Status: Enrolling
Updated: 12/27/2017
Laureate Institute for Brian Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
A Randomized, Open-label, Cross-over, 2-period Study to Assess the Relative Bioavailability Between 80 mg LY03005 Versus 50 mg Desvenlafaxine Comparator (Pristiq®) Under Fasting Condition After Single Dose Administration in Healthy Subjects
Status: Enrolling
Updated:  1/2/2018
Clinilabs, Inc.
mi
from
Eatontown, NJ
Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
A Randomized, Open-label, Cross-over, 2-period Study to Assess the Relative Bioavailability Between 80 mg LY03005 Versus 50 mg Desvenlafaxine Comparator (Pristiq®) Under Fasting Condition After Single Dose Administration in Healthy Subjects
Status: Enrolling
Updated: 1/2/2018
Clinilabs, Inc.
mi
from
Eatontown, NJ
Click here to add this to my saved trials